SG46741A1 - Pyridazinone derivatives and processes for preparing the same - Google Patents
Pyridazinone derivatives and processes for preparing the sameInfo
- Publication number
- SG46741A1 SG46741A1 SG1996010164A SG1996010164A SG46741A1 SG 46741 A1 SG46741 A1 SG 46741A1 SG 1996010164 A SG1996010164 A SG 1996010164A SG 1996010164 A SG1996010164 A SG 1996010164A SG 46741 A1 SG46741 A1 SG 46741A1
- Authority
- SG
- Singapore
- Prior art keywords
- preparing
- processes
- same
- pyridazinone derivatives
- pyridazinone
- Prior art date
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Optical Couplings Of Light Guides (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16062095 | 1995-06-27 | ||
| JP1985996 | 1996-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG46741A1 true SG46741A1 (en) | 1998-02-20 |
Family
ID=26356726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996010164A SG46741A1 (en) | 1995-06-27 | 1996-06-26 | Pyridazinone derivatives and processes for preparing the same |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5698554A (es) |
| EP (1) | EP0751132B1 (es) |
| KR (1) | KR970061873A (es) |
| CN (1) | CN1144802A (es) |
| AR (1) | AR002602A1 (es) |
| AT (1) | ATE195937T1 (es) |
| AU (1) | AU694955B2 (es) |
| BG (1) | BG62768B1 (es) |
| CA (1) | CA2179939A1 (es) |
| DE (1) | DE69610036T2 (es) |
| DK (1) | DK0751132T3 (es) |
| ES (1) | ES2151110T3 (es) |
| GR (1) | GR3034910T3 (es) |
| HU (1) | HUP9601766A3 (es) |
| IL (1) | IL118631A (es) |
| MY (1) | MY132263A (es) |
| NO (1) | NO311084B1 (es) |
| PT (1) | PT751132E (es) |
| RU (1) | RU2131419C1 (es) |
| SG (1) | SG46741A1 (es) |
| TW (1) | TW432052B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2235911C (en) * | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
| CO5200835A1 (es) * | 1999-09-28 | 2002-09-27 | Bayer Corp | Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis |
| KR20030061051A (ko) * | 2002-01-07 | 2003-07-18 | 대한민국 (경상대학교 총장) | 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도 |
| AR050552A1 (es) * | 2004-09-02 | 2006-11-01 | Osi Pharm Inc | Mercaptoamidas como inhibidores de histona desacetilasa |
| CN101443317B (zh) * | 2006-03-17 | 2011-07-06 | 住友化学株式会社 | 哒嗪酮化合物及其作为除草剂的用途 |
| MX2009000884A (es) * | 2006-07-25 | 2009-06-05 | Cephalon Inc | Derivados de piridizinona. |
| AU2008322676B9 (en) * | 2007-11-15 | 2014-03-27 | Msd Italia S.R.L. | Pyridazinone derivatives as PARP inhibitors |
| EP2547203A4 (en) | 2010-03-19 | 2013-12-25 | Purdue Research Foundation | CCR5 MODULATORS TO TREAT HIV |
| CN103201279A (zh) | 2010-11-05 | 2013-07-10 | 赛诺米克斯公司 | 作为trpm8的调节剂有用的化合物 |
| WO2012177896A1 (en) | 2011-06-24 | 2012-12-27 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| BR112013033316A2 (pt) | 2011-06-24 | 2017-01-31 | Amgen Inc | antagonista de trpm8 e seu uso em tratamentos |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| MX389514B (es) | 2015-10-01 | 2025-03-20 | Firmenich Incorporated | Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8). |
| EP3442972B1 (en) | 2016-04-15 | 2020-03-04 | AbbVie Inc. | Bromodomain inhibitors |
| CN113226322A (zh) * | 2018-10-30 | 2021-08-06 | 诺维逊生物股份有限公司 | 作为bet抑制剂的杂环化合物 |
| CN113272014B (zh) | 2018-11-06 | 2026-01-27 | 艾知怀斯治疗学公司 | 哒嗪酮化合物及其用途 |
| AU2019374812B2 (en) | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| PL3877376T3 (pl) | 2018-11-06 | 2024-02-19 | Edgewise Therapeutics, Inc. | Pochodne pirydazynonu i ich zastosowania |
| CA3145827A1 (en) | 2019-07-02 | 2021-01-07 | Nuvation Bio Inc. | Heterocyclic compounds as bet inhibitors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6053022B2 (ja) * | 1977-04-07 | 1985-11-22 | ウェルファイド株式会社 | ピリダジノン誘導体 |
| GB8323553D0 (en) * | 1983-09-02 | 1983-10-05 | Smith Kline French Lab | Pharmaceutical compositions |
| JPS6193169A (ja) * | 1984-10-12 | 1986-05-12 | Sankyo Co Ltd | ピリダジノン誘導体及びその製法 |
| EP0194548A3 (de) * | 1985-03-12 | 1988-08-17 | Dr. Karl Thomae GmbH | Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE3508692A1 (de) | 1985-03-12 | 1986-09-18 | Dr. Karl Thomae Gmbh, 7950 Biberach | 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung |
| KR860007219A (ko) * | 1985-03-12 | 1986-10-08 | 베쩰, 좀머 | 설포닐아미노에틸 화합물의 제조방법 |
| DE3623944A1 (de) | 1986-07-16 | 1988-02-11 | Thomae Gmbh Dr K | Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| JPS63145272A (ja) * | 1986-12-09 | 1988-06-17 | Morishita Seiyaku Kk | ４，５−ジヒドロ−６−（４−置換フエニル）−３（２ｈ）−ピリダジノン誘導体 |
| SU1486061A3 (ru) * | 1987-03-26 | 1989-06-07 | Mitsubishi Chem Ind | Способ получения производных пиридазинона или их солей |
| DE3728491A1 (de) * | 1987-08-26 | 1989-03-09 | Heumann Pharma Gmbh & Co | Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4134467A1 (de) * | 1991-10-18 | 1993-04-22 | Thomae Gmbh Dr K | Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| WO1992015558A1 (fr) | 1991-03-01 | 1992-09-17 | Zeria Pharmaceutical Co., Ltd. | Derive d'indane et antagoniste de thromboxane le contenant |
| CA2099743A1 (en) * | 1992-07-02 | 1994-01-03 | Akihiko Ishida | Pyridazinone derivatives and processes for preparing the same |
| JP2616584B2 (ja) * | 1992-07-02 | 1997-06-04 | 田辺製薬株式会社 | ピリダジノン誘導体及びその製法 |
| CA2138812A1 (en) * | 1993-12-28 | 1995-06-29 | Akihiko Ishida | Indane derivative and processes for preparing the same |
| CA2139088A1 (en) * | 1993-12-28 | 1995-06-29 | Akihiko Ishida | Indane derivatives, processes for preparing the same and synthetic intermediate of the same |
| JP2757353B2 (ja) * | 1993-12-28 | 1998-05-25 | 田辺製薬株式会社 | インダン誘導体、その製法及びその合成中間体 |
-
1996
- 1996-06-01 IL IL11863196A patent/IL118631A/en not_active IP Right Cessation
- 1996-06-21 NO NO19962643A patent/NO311084B1/no unknown
- 1996-06-26 HU HU9601766A patent/HUP9601766A3/hu unknown
- 1996-06-26 TW TW085107678A patent/TW432052B/zh not_active IP Right Cessation
- 1996-06-26 MY MYPI96002583A patent/MY132263A/en unknown
- 1996-06-26 SG SG1996010164A patent/SG46741A1/en unknown
- 1996-06-26 RU RU96112778/04A patent/RU2131419C1/ru not_active IP Right Cessation
- 1996-06-26 AR AR10332096A patent/AR002602A1/es unknown
- 1996-06-26 CA CA002179939A patent/CA2179939A1/en not_active Abandoned
- 1996-06-27 KR KR1019960024718A patent/KR970061873A/ko not_active Ceased
- 1996-06-27 CN CN96106873A patent/CN1144802A/zh active Pending
- 1996-06-27 PT PT96110412T patent/PT751132E/pt unknown
- 1996-06-27 ES ES96110412T patent/ES2151110T3/es not_active Expired - Lifetime
- 1996-06-27 BG BG100684A patent/BG62768B1/bg unknown
- 1996-06-27 US US08/671,485 patent/US5698554A/en not_active Expired - Fee Related
- 1996-06-27 EP EP96110412A patent/EP0751132B1/en not_active Expired - Lifetime
- 1996-06-27 AT AT96110412T patent/ATE195937T1/de not_active IP Right Cessation
- 1996-06-27 DK DK96110412T patent/DK0751132T3/da active
- 1996-06-27 DE DE69610036T patent/DE69610036T2/de not_active Expired - Fee Related
- 1996-06-27 AU AU56221/96A patent/AU694955B2/en not_active Ceased
-
1997
- 1997-08-25 US US08/917,113 patent/US5808065A/en not_active Expired - Fee Related
-
2000
- 2000-11-24 GR GR20000402616T patent/GR3034910T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL118631A0 (en) | 1996-10-16 |
| BG62768B1 (bg) | 2000-07-31 |
| RU2131419C1 (ru) | 1999-06-10 |
| PT751132E (pt) | 2000-12-29 |
| DE69610036D1 (de) | 2000-10-05 |
| AR002602A1 (es) | 1998-03-25 |
| HUP9601766A2 (en) | 1997-02-28 |
| AU5622196A (en) | 1997-01-09 |
| US5698554A (en) | 1997-12-16 |
| AU694955B2 (en) | 1998-08-06 |
| BG100684A (bg) | 1997-03-31 |
| NO962643D0 (no) | 1996-06-21 |
| HUP9601766A3 (en) | 1998-04-28 |
| DE69610036T2 (de) | 2001-04-12 |
| NO311084B1 (no) | 2001-10-08 |
| EP0751132A1 (en) | 1997-01-02 |
| CA2179939A1 (en) | 1996-12-28 |
| ATE195937T1 (de) | 2000-09-15 |
| IL118631A (en) | 2002-05-23 |
| DK0751132T3 (da) | 2000-11-13 |
| ES2151110T3 (es) | 2000-12-16 |
| NO962643L (no) | 1996-12-30 |
| US5808065A (en) | 1998-09-15 |
| EP0751132B1 (en) | 2000-08-30 |
| KR970061873A (ko) | 1997-09-12 |
| GR3034910T3 (en) | 2001-02-28 |
| MY132263A (en) | 2007-09-28 |
| TW432052B (en) | 2001-05-01 |
| HU9601766D0 (en) | 1996-08-28 |
| CN1144802A (zh) | 1997-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000449A3 (en) | N-subsituted dioxothiazolidylbenzamide derivatives and process for producing the same | |
| SG46741A1 (en) | Pyridazinone derivatives and processes for preparing the same | |
| GB9511077D0 (en) | 17B-Substituted-6-azasteroid derivatives | |
| ZA953356B (en) | Benzocycloalkylazolethione derivatives | |
| ZA969220B (en) | Nucleoside derivatives and process for preparing the same | |
| EP0692482A3 (en) | 1-pyridyltetrazolinone derivatives | |
| AU6629496A (en) | Antiviral agent and process for preparing the same | |
| IL112519A0 (en) | 5-heteroarylindole derivatives | |
| HRP931016A2 (en) | Thienothiazin derivatives, process for the preparation and application thereof | |
| HU9503582D0 (en) | Thienopyridon derivatives | |
| GB9511365D0 (en) | Pyridazino-indole derivatives | |
| SG47141A1 (en) | Sulfonamide derivative and process for preparing the same | |
| HUP0002717A3 (en) | 13-deoxyanthracycline derivatives and processes for preparing them | |
| GB2302691B (en) | Oxaindene derivatives and process for the preparation thereof | |
| GB2329385B (en) | (3-Oxoisoindolin-1-ylidine)propandinitrile derivatives and method for preparing the same | |
| HUP9601521A2 (en) | Substituted quinoline-intermediates and process for preparation the same | |
| ZA965416B (en) | Pyridazinone derivatives and process for preparing the same. | |
| HUP9601520A3 (en) | Substituted quinoline-intermediates and process for preparation the same | |
| NZ332994A (en) | Iron-casein complex and process for preparing the same | |
| GB2287463B (en) | Bis-anthracycline derivatives | |
| GB2291425B (en) | 7-Diazo-beta-lactam derivatives | |
| IL108277A0 (en) | 3-Metyl-7-n-propylxantihine derivatives and processes for the preparation thereof | |
| EP0738707A3 (en) | Dianilinoglutacondialdehyde compounds and process for their preparation | |
| ZA9610708B (en) | Oxaindene derivatives and process for the preparation thereof. | |
| ZA934785B (en) | 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof. |